Abstract
Women with polycystic ovarian syndrome (PCOS) represent a unique population, with long term implications on fertility, obesity and diabetic complications, which need to be addressed. In our study 80 consecutive PCOS women were screened. The prevalence of various clinical parameters like menstrual irregularities, obesity, hypertension, thyroid problem and diabetes were compared between case-control groups. It was observed that 78.75% PCOS patients had abnormal menstrual cycle. 10% of the PCOS patients were found to be obese whereas in case of control group the percentage were shown is only 3.75%. We found BMI and PCOS were significantly associated (p-value <0.0001). But we did not find any significant association of waist-hip ratio with PCOS (p-value is 0.2120). 25% of the PCOS patients were hypertensive. Thyroid disorder was reported in 25% in PCOS and 2.5% in control group. These PCOS women who were more obese had a significantly higher prevalence of glucose intolerance compared to control women (P= 0.005). The goal of this study was to help improve awareness and discuss the clinical implications of the coexistence of these disorders in this particular patient population.
References
Balen, A.H., Conway, G.S., Kaltas, G., Techatraisak, K., Manning, P.J., West, C et al (1995). Polycystic ovarian syndrome: The spectrum of disorder in 1741 patients. Hum Reprod, 10, 2107-11.
Corbould, A., Kim, Y.B., Youngren, J.F., Pender, C., Kahn, B.B., Lee A and Dunaif, A (2005). Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling. Am J Physiol Endocrinol Metab, 288(5), E1047 - E1054.
Ehrmann, D (2005). Medical progress: Polycystic ovarian syndrome. The New England Journal of Medicine, 352, 1223-1236.
Elsenbruch, S., Hahn, S., Kowalsky, D et al (2003). Quality of life, Psychosocial well being and sexual satisfaction in women with polysystic ovarian syndrome. J clin endocrinol metab, 88, 5801-7.
Frank, S., Gharani, N and Mc Cathy, M (2001). Candidate’s genes in Polycystic Ovary Syndrome. Hum Reprod; update, 405-410.
Ganie, M.A., Marwaha, R.K., Aggarwal, R., Singh, S (2010). High prevalence of polycystic ovary syndrome characteristics in girls with euthyroid chronic lymphocytic thyroiditis: a case-control study. European Journal of Endocrinology, 162(6), 1117-1122.
Heather, R. Peppard, J.M., Maria, J. I., John, E. Nestler (2001). Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes. Diabetes Care, 24, 1050-2.
Lim, S.S., Davis, M.J., Norman, R.J and Moran, L.J (2012).Overweight, obesity and central obesity in women with polycystic ovarian syndrome: A systemic review and meta-analysis. Hum Reprod update, 18 (6), 618-637.
Majumdar. A and Singh, T.A (2009). Comparison of clinical features and health manifestations in lean vs obese Indian women with polycystic ovarian syndrome. J Hum Reprod Sci, 2, 12-17.
Raber, W., Nowotny, P., Vytiska-Binstorfer, E., Vierhapper, H (2003). Thyroxine treatment modi?ed in infertile women according to thyroxine-releasing hormone testing: 5 year follow-up of 283 women referred after exclusion of absolute causes of infertility. Hum Reprod18, 707–14.
Robert, J.N., Micheel J.D., Jonathan L and Lisa J.M (2002). The role of lifestyle modification in polycystic ovary syndrome. Trends Endocrinol. Metab, 13(6), 251-57.
Setian, N.S (2007). Hypothyroidism in children: diagnosis and treatment. J Pediatr (Rio J), 83, S209–16.
Wajner, S.M., Wagner, M.S., Maia, A.L (2009). Clinical implications of altered thyroid status in male testicular function. Arq Bras Endocrinol Metabol, 53, 976–82.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright (c) 2020 Array